Literature DB >> 4717914

'Immune' RNA-mediated transfer of delayed skin reactivity in patients with Hodgkin's disease.

T Han.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4717914      PMCID: PMC1553783     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  19 in total

1.  Studies on delayed hypersensitivity in Hodgkin's disease.

Authors:  A C AISENBERG
Journal:  J Clin Invest       Date:  1962-11       Impact factor: 14.808

2.  Sedimentation characteristics of rapidly labelled RNA from HeLa cells.

Authors:  K SCHERRER; J E DARNELL
Journal:  Biochem Biophys Res Commun       Date:  1962-06-04       Impact factor: 3.575

3.  Delayed-type hypersensitivity and the immunology of Hodgkin's disease, with a parallel examination of sarcoidosis.

Authors:  M W Chase
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

4.  Impaired in vitro lymphocyte transformation in Hodgkin's disease.

Authors:  E M Hersh; J J Oppenheim
Journal:  N Engl J Med       Date:  1965-11-04       Impact factor: 91.245

5.  Lymphocyte response to phytohemagglutinin in Hodgkin's disease, lymphatic leukemia and lymphosarcoma.

Authors:  S Trubowitz; B Masek; A Del Rosario
Journal:  Cancer       Date:  1966-12       Impact factor: 6.860

6.  Lymphocyte transformation and chromosome studies in Hodgkin's disease.

Authors:  S D Lawler; C R Pentycross; B R Reeves
Journal:  Br Med J       Date:  1967-09-16

7.  Impaired phytohaemagglutinin-induced cytotoxicity in vitro of lymphocytes from patients with Hodgkin's disease or chronic lymphatic leukaemia.

Authors:  G Holm; P Perlmann; B Johansson
Journal:  Clin Exp Immunol       Date:  1967-05       Impact factor: 4.330

8.  Lymphocyte transformation by phytohemagglutinin. I. In Hodgkin's Disease.

Authors:  J W Thomas; W Boldt; G Horrocks; B Low
Journal:  Can Med Assoc J       Date:  1967-09-30       Impact factor: 8.262

9.  Delayed hypersensitivity in man: a correlate in vitro and transfer by an RNA extract.

Authors:  D E Thor
Journal:  Science       Date:  1967-09-29       Impact factor: 47.728

10.  ANTIBODY PLAQUE FORMATION BY NORMAL MOUSE SPLEEN CELL CULTURES EXPOSED IN VITRO TO RNA FROM IMMUNE MICE.

Authors:  H FRIEDMAN
Journal:  Science       Date:  1964-11-13       Impact factor: 47.728

View more
  4 in total

1.  In vitro transfer of tumour-specific immunity with human 'immune' RNA.

Authors:  T Han; H Takita; P C Marabella; A Mittelman
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

2.  Adoptive transfer of cell-mediated immunity to tuberculin using RNA from tuberculin-sensitive subjects.

Authors:  T Han; J L Pauly; A Mittelman
Journal:  Immunology       Date:  1975-01       Impact factor: 7.397

Review 3.  Transfer of tumor specific immunity with "immune" RNA: prospects for the treatment of human cancer.

Authors:  D Fritze; D H Kern; Y H Pilch
Journal:  Klin Wochenschr       Date:  1976-09-15

4.  Release of soluble "blocking" and "suppressor" factors from normal lymphocytes treated with RNA from spleens of tumour-bearing mice.

Authors:  K J Pennline; S B Evans; J F Nawrocki; J C Rees; C S Johnson; D A Vallera; M C Dodd
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.